I am making a prediction that this drug will be released by Gilead in 2017/2018.
Why? Gilead loses the patent on Viread in 2017/2018. Their cash cow will have run its course and they will be more than happy to release this drug to continue to reap the money for HBV treatment.
There is one thing I remember Dr. Gish telling me that I won't forget. He said "you know Gilead is working on a drug that will make it so you don't have to take Viread for ever. It's kind of odd that they'd be working on a drug that will eliminate their Viread income".
Not really. If they release it when Viread loses patent, it's a win-win for them!
Had appt with Gish - he said there is unreleased data from clinical trials showing GS 9620 has been effective, and non-toxic in escalating doses. He also said clinical trials are still ongoing and they've relaxed the inclusion criteria, so others may be able to join (veteranB).
The Content on this Site is presented in a summary fashion, and is intended to be used for educational and entertainment purposes only. It is not intended to be and should not be interpreted as medical advice or a diagnosis of any health or fitness problem, condition or disease; or a recommendation for a specific test, doctor, care provider, procedure, treatment plan, product, or course of action. Med Help International, Inc. is not a medical or healthcare provider and your use of this Site does not create a doctor / patient relationship. We disclaim all responsibility for the professional qualifications and licensing of, and services provided by, any physician or other health providers posting on or otherwise referred to on this Site and/or any Third Party Site. Never disregard the medical advice of your physician or health professional, or delay in seeking such advice, because of something you read on this Site. We offer this Site AS IS and without any warranties. By using this Site you agree to the following Terms and Conditions. If you think you may have a medical emergency, call your physician or 911 immediately.